Optimal Timing of Surgery Following Neoadjuvant Therapy for Surgical and Oncological Outcomes in Advanced Esophageal Squamous Cell Carcinoma: An Exploratory Analysis of JCOG1109
Time to surgery following neoadjuvant therapy did not significantly influence prognosis in advanced ESCC. Nonetheless, prolonged intervals after chemoradiotherapy may increase surgical complexity and leakage risk, in addition to elevating the potential for adverse prognostic effects associated with excessive delays.
Authors
- Keiko Minashi (ORCID: https://orcid.org/0000-0003-1513-7117)
- Tetsuya Abe
- Hiroki Hara
- Yasue Kimura
- Ken Kato
- Hiroyuki Daiko
- Ryunosuke Machida
- Hiroya Takeuchi
- Takahiro Tsushima
- Kazuo Koyanagi
- Yoshinori Ito
- Ryosuke Kita
- Kohei Akiyoshi
- Satoru Matsuda
- Keita Sasaki
- Haruhiko Fukuda
- Hirofumi Kawakubo
- Kenji Amagai
Institutions
- SHOWA Medical University (JP)
- Tokai University (JP)
- Keio University (JP)
- Kyoto University (JP)
- Hamamatsu University School of Medicine (JP)
- Shizuoka Cancer Center (JP)
- National Cancer Center (US)
- National Hospital Organization Kyushu Cancer Center (JP)
- Osaka City General Hospital (JP)
- Chiba Cancer Center (JP)
- Saitama Cancer Center (JP)
- Aichi Cancer Center (JP)
- Ibaraki Prefectural Central Hospital (JP)
- Japan Clinical Cancer Research Organization (JP)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1245/s10434-025-19050-6
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00